Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.27 is 42% below its 5-year average of 12.45, near the low end of its 5-year range (6.04–22.14).
As of the fiscal period ended Tuesday, June 30, 2026. 32.05% below its 12-month average of 10.70.
Reported quarterly current ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 7.27.
CURRENT RATIO
7.27
CURRENT RATIO AVG TTM
10.70
CURRENT RATIO AVG 3Y
9.93
CURRENT RATIO AVG 5Y
12.45
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-32.05%
CURRENT VS 3Y AVG
-26.78%
CURRENT VS 5Y AVG
-41.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+93.83%
vs the sector median at left
Market Cap
$6.48B
Current Ratio
2.20
TTM Avg
1.79
3Y Avg
1.77
5Y Avg
1.94
Market Cap
$6.20B
Current Ratio
3.45
TTM Avg
3.83
3Y Avg
5.53
5Y Avg
6.55
Market Cap
$5.92B
Current Ratio
31.18
TTM Avg
15.58
3Y Avg
12.00
5Y Avg
10.69
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | $6.51B | 7.27 | 10.70 | 9.93 | 12.45 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.52B | 0.93 | 1.84 | 2.80 | 3.67 |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 3.06 | 4.11 | 4.19 | 3.61 |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.48B | 2.20 | 1.79 | 1.77 | 1.94 |
| Chemed Corporation (CHE)vs › | $6.65B | 0.91 | 1.21 | 1.24 | 1.14 |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.20B | 3.45 | 3.83 | 5.53 | 6.55 |
| Alkermes plc (ALKS)vs › | $6.97B | 2.30 | 3.29 | 2.93 | 2.75 |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.92B | 31.18 | 15.58 | 12.00 | 10.69 |
| GRAIL Inc. (GRAL)vs › | $5.90B | 10.95 | 11.32 | 6.44 | 5.89 |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 3.90 | 3.54 | 4.15 | 5.24 |
Current Ratio
7.27
Quick Ratio
7.27
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.27 |
| 2026-03-31 | 9.09 |
| 2025-12-31 | 15.74 |
| 2025-09-30 | 9.07 |
| 2025-06-30 | 12.32 |
| 2025-03-31 | 11.16 |
| 2024-12-31 | 6.04 |
| 2024-09-30 | 7.61 |
| 2024-06-30 | 13.08 |
| 2024-03-31 | 13.70 |
| 2023-12-31 | 22.14 |
| 2023-09-30 | 7.23 |
| 2023-06-30 | 6.82 |
| 2023-03-31 | 9.34 |
| 2022-12-31 | 11.01 |
| 2022-09-30 | 13.41 |
| 2022-06-30 | 21.48 |
| 2022-03-31 | 11.52 |
| 2021-12-31 | 14.87 |
| 2021-09-30 | 19.86 |
| 2021-06-30 | 18.75 |
| 2021-03-31 | 21.79 |
| 2020-12-31 | 26.05 |
| 2020-09-30 | 35.15 |
| 2020-06-30 | 14.64 |
| 2020-03-31 | 7.12 |
| 2019-12-31 | 8.58 |
| 2019-09-30 | 5.22 |
| 2019-06-30 | 22.77 |
| 2019-03-31 | 0.49 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
